https://www.synconaltd.com/news-insights/news/ionctura-expands-roginolisib-trials-to-the-us-advancing-multi-indication-strategy-in-oncology/
iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules.
expandstrialsusadvancingmulti
https://www.pharmaceutical-technology.com/analyst-comment/immuno-oncology-sees-solid-growth-spurt/
The Immuno-oncology space became more established as a pillar of cancer care in 2018, with approvals and positive data in new, difficult-to-treat indications
oncology researchimmunospatenewus
https://www.pharmacytimes.com/sap-partner/health-system-oncology/the-us-oncology-network
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
us oncologynetwork healthsystemsappartners
https://www.uclahealth.org/departments/radonc/about-us
Welcome to the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. Michael L. Steinberg, MD, FASTRO, FACR, FACRO Michael...
radiation oncologyucla healthus
https://www.thermofisher.com/us/en/home/life-science/cancer-research/cancer-genomics/liquid-biopsy-cancer-research-applications/oncomine-cell-free-dna-assays-liquid-biopsy-clinical-research.html
Ion Torrent™ Oncomine™ cfDNA assays are tumor type–specific, multibiomarker next-generation sequencing (NGS) assays that enable detection of somatic...
thermo fisher scientificclinical oncologyassaysresearch